Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

2020

  1. Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis

    Medicina Clinica, Vol. 155, Núm. 5, pp. 220.e1-220.e12

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2018

  1. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis

    Medicine (United States), Vol. 96, Núm. 42

  2. Treatment recommendations for non-infectious anterior uveitis

    Medicina Clinica, Vol. 149, Núm. 12, pp. 552.e1-552.e12

2015

  1. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368

2013

  1. Biologic Therapy In Refractory Uveitis Of Behcet's Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients

    ARTHRITIS AND RHEUMATISM

  2. Short and Long-Term Biological Therapy In Refractory Uveitis Of Behcet's Syndrome. Multicenter Study Of 124 Patients

    ARTHRITIS AND RHEUMATISM